Effect of an Artificial Pancreas in Patients Undergoing Pancreatic Resection
NCT ID: NCT00661648
Last Updated: 2009-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
50 participants
INTERVENTIONAL
2007-04-30
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)
NCT02838966
Effects of Immunonutrition in Patients Undergoing Pancreaticoduodenectomy
NCT00668876
Enteral vs. Oral Nutrition After Pancreatoduodenectomy
NCT05042882
Clinical Validation of Nutritional Supplements("Ketogenic Plus") Developed for Pancreaticobiliary Cancer Patients
NCT03510429
Structured Follow-up Intervention on Glucose Status After Pancreatic Cancer Surgery
NCT06774170
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
glucose levels were controlled using sliding scale
No interventions assigned to this group
2
received programmed infusions of insulin determined by the control algorithm of the artificial pancreas
the closed-loop STG-22 system (Nikkiso Inc, Tokyo, Japan)
artificial pancreas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
the closed-loop STG-22 system (Nikkiso Inc, Tokyo, Japan)
artificial pancreas
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* sign of distant metastasis
* respiratory, renal, or heart disease
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kochi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kochi Medical School
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Takehiro Okabayashi, MD
Role: STUDY_DIRECTOR
Kochi Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kochi Medical School
Nankoku, Kochi, Japan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Kochi University
Identifier Type: -
Identifier Source: secondary_id
TGC-AP-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.